What You Need to Know
The Lesotho Ministry of Health has launched Lenacapavir injection in Botha-Bothe district, marking a significant advancement in HIV prevention. This innovative treatment, administered biannually, aims to improve adherence and access to prevention methods, supporting the national goal of eliminating new HIV infections by 2030. Stakeholders are committed to fostering a healthier, HIV-free future for
Africa-Press – Lesotho. The ministry of health officially launched Lenacapavir injection in Botha-Bothe district making a major step forward in HIV prevention in Lesotho.
Lenacapavir is administered just once every six months, offering a more convenient and sustained form of protection.
Health stakeholders emphasized that this innovation could significantly strengthen HIV prevention efforts in Lesotho by reducing the challenges associated with daily medication adherence and improving access to reliable prevention methods.
The introduction of Lenacapavir also supports Lesotho’s national goal of ending new HIV infections by 2030.
All stakeholders, Government leaders, healthcare organizations, and community members, all came together to reaffirm their commitment to work together to build a healthier, HIV-free future generation.
Lesotho has faced significant challenges in combating HIV, with a high prevalence rate affecting many communities. The introduction of Lenacapavir represents a pivotal moment in the country’s public health strategy, as it aligns with global efforts to enhance treatment accessibility and adherence. By reducing the burden of daily medication, this new approach aims to empower individuals and communities in their fight against HIV, ultimately contributing to the national objective of eradicating new infections by 2030.
